Mechanism of angiotensin-converting enzyme inhibitors in the treatment of dilated cardiomyopathy based on a protein interaction network and molecular docking.

Authors:
Zhong G; Chen C; Wu S; Chen J; Han Y and 4 more

Journal:
Cardiovasc Diagn Ther

Publication Year: 2023

DOI:
10.21037/cdt-23-112

PMCID:
PMC10315431

PMID:
37405022

Journal Information

Full Title: Cardiovasc Diagn Ther

Abbreviation: Cardiovasc Diagn Ther

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Cardiac & Cardiovascular Systems

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"gene chip data named gse42955 submitted by molina-navarro et al ( ) were selected by searching the gene expression omnibus (geo) database ( https://www ncbi nlm nih gov/gds ) for samples with "human (homo sapiens)" as the study species."

Code Sharing
Evidence found in paper:

"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://cdt.amegroups.com/article/view/10.21037/cdt-23-112/coif). The authors have no conflicts of interest to declare."

Evidence found in paper:

"Funding: The research was funded by the Shenzhen Traditional Chinese Medicine Hospital “3030 Program” Chinese Medicine Clinical Research Project (No. G3030202128)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025